COAGULATION FACTORS

Clinical trials for COAGULATION FACTORS explained in plain language.

Never miss a new study

Get alerted when new COAGULATION FACTORS trials appear

Sign up with your email to follow new studies for COAGULATION FACTORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Heart stent patients: could a tailored blood thinner dose reduce risks?

Disease control Recruiting now

This study looks for the safest and most effective dose of blood thinners (P2Y12 inhibitors) for people who have had a heart stent placed. About 355 participants will try different doses to find one that keeps blood clotting at a healthy level—not too high (which can cause clots)…

Matched conditions: COAGULATION FACTORS

Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control

Last updated May 17, 2026 03:53 UTC

COAGULATION FACTORS

Get alerted when new COAGULATION FACTORS trials appear

Heart stent patients: could a tailored blood thinner dose reduce risks?